ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,881.63
      -0.43%
      US Tech 100
      20,449.60
      -0.85%
      Dow Jones
      42,544.22
      -0.07%
      Brent Oil
      73.855
      -1.33%
      Bitcoin
      94,449.46
      1.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Immupharma Plc (IMM) Quote

      Immupharma Plc

      Immupharma Plc (IMM)

      Immutep Limited
      International Metals Mining Corp
      1.2075
      0.00
      (0.00%)
      Closed January 01 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.2075
      Bid
      1.12
      Ask
      1.29
      Volume
      183,678
      0.00 Day's Range 0.00
      0.83 52 Week Range 2.90
      Market Cap
      5.029M
      Previous Close
      1.2075
      Open
      -
      Last Trade
      11038
      @
      1.1778
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,452,945
      Shares Outstanding
      416,440,000
      Dividend Yield
      -
      PE Ratio
      -1.73
      Earnings Per Share (EPS)
      -0.01
      Revenue
      -
      Net Profit
      -2.92M

      About Immupharma Plc

      Sector
      Finance Services
      Industry
      Finance Diversified
      Website
      www.immupharma.com
      Headquarters
      London, Gbr
      Founded
      2006
      Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 1.21p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 2.90p.

      Immupharma currently has 416,440,000 shares outstanding. The market capitalization of Immupharma is £5.03 million. Immupharma has a price to earnings ratio (PE ratio) of -1.73.

      Ask ADVFN Intelligence (AI)

      IMM Latest News

      More News

      Immupharma PLC Change of Auditor

      Immupharma PLC 23 December 2024        23 December 2024   ImmuPharma PLC ("ImmuPharma" or the "Company") Change of Auditor   ImmuPharma PLC (LSE: IMM), the specialist drug discovery and...

      December 23 2024
      RNS Regulatory News

      Immupharma PLC Holding(s) in Company

      Immupharma PLC 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

      December 10 2024
      RNS Regulatory News

      Immupharma PLC Appointment of Company Secretary

      Immupharma PLC 04 December 2024                                                                                                                                                                  ...

      December 04 2024
      RNS Regulatory News

      ImmuPharma narrows losses in first half as expenses fall

      ImmuPharma PLC on Monday expressed optimism about the potential of its pipeline, after narrowing pretax loss in the f ...

      September 09 2024
      Alliance News

      ImmuPharma obtains second warrant extension with Incanthera

      ImmuPharma PLC said on Monday it had extended its warrants in Incanthera PLC for the second time, valid now until Mar ...

      September 09 2024
      Alliance News

      Immupharma PLC Extension of Warrants in Incanthera to 31 Mar 2025

      Immupharma PLC 09 September 2024                                                                                                                                                                 ...

      September 09 2024
      RNS Regulatory News

      Immupharma PLC Half-year Report

      Immupharma PLC 09 September 2024   RNS: RELEASE | 9 September 2024       ImmuPharma PLC ("ImmuPharma" or the "Company")   INTERIM RESULTS for the six months ended 30 June 2024   ImmuPharma PLC...

      September 09 2024
      RNS Regulatory News

      Immupharma PLC Holding(s) in Company

      Immupharma PLC 06 August 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

      August 06 2024
      RNS Regulatory News

      Immupharma PLC Result of AGM

      Immupharma PLC 28 June 2024       RNS: RELEASE                                                                                                                                             ...

      June 28 2024
      RNS Regulatory News

      EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

      The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...

      June 05 2024
      Alliance News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.142513.38028169011.0651.281.06510481531.2218516DE
      40.207520.7511.3650.8517354071.17776637DE
      12-0.6725-35.77127659571.881.9950.8514529451.37346891DE
      26-0.9925-45.11363636362.22.20.8513409001.53291754DE
      52-0.4925-28.97058823531.72.90.8317170041.72385437DE
      156-5.7925-82.7579.50.8315789023.08420248DE
      260-14.8925-92.516.121.30.8314039535.770507DE

      IMM - Frequently Asked Questions (FAQ)

      What is the current Immupharma share price?
      The current share price of Immupharma is 1.2075p
      How many Immupharma shares are in issue?
      Immupharma has 416,440,000 shares in issue
      What is the market cap of Immupharma?
      The market capitalisation of Immupharma is GBP 5.03M
      What is the 1 year trading range for Immupharma share price?
      Immupharma has traded in the range of 0.83p to 2.90p during the past year
      What is the PE ratio of Immupharma?
      The price to earnings ratio of Immupharma is -1.73
      What is the reporting currency for Immupharma?
      Immupharma reports financial results in GBP
      What is the latest annual profit for Immupharma?
      The latest annual profit of Immupharma is GBP -2.92M
      What is the registered address of Immupharma?
      The registered address for Immupharma is ONE BARTHOLOMEW CLOSE, LONDON, EC1A 7BL
      What is the Immupharma website address?
      The website address for Immupharma is www.immupharma.com
      Which industry sector does Immupharma operate in?
      Immupharma operates in the FINANCE DIVERSIFIED sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VALValirx Plc
      0.775p
      (24.00%)
      		133.41M
      TRAFTrafalgar Property Group Plc
      0.03p
      (20.00%)
      		7.96M
      KODKodal Minerals Plc
      0.455p
      (12.35%)
      		76.26M
      SCESurface Transforms Plc
      0.46p
      (12.20%)
      		17.27M
      ZEDZenova Group Plc
      0.75p
      (11.11%)
      		1.39M
      DGIDg Innovate Plc
      0.0225p
      (-70.39%)
      		809.27M
      ADMEAdm Energy Plc
      0.25p
      (-41.18%)
      		3.39M
      CLCOCloudcoco Group Plc
      0.175p
      (-22.22%)
      		3.05M
      KLSOKelso Group Holdings Plc
      2.60p
      (-16.13%)
      		6.14M
      WEBWebis Holdings Plc
      0.055p
      (-15.38%)
      		1.35M
      DGIDg Innovate Plc
      0.0225p
      (-70.39%)
      		809.27M
      NTVONativo Resources Plc
      0.0019p
      (-5.00%)
      		503.63M
      TRPTower Resources Plc
      0.036p
      (-2.70%)
      		210.92M
      SYMESupply@me Capital Plc
      0.0035p
      (-11.39%)
      		168.54M
      PREMPremier African Minerals Limited
      0.04p
      (-9.09%)
      		158M

      Discussion

      View Full Feed
      manibiotech manibiotech 3 minutes ago
      Yep
      He has batting average of 0.0000
      NWBO
      cjstocksup cjstocksup 4 minutes ago
      Looks like a bomb was set up in the CyberTruck at Trump Tower
      https://x.com/CYBRCAB/status/1874537286857273798
      manibiotech manibiotech 4 minutes ago
      FDA doesn't require large scale commercial manufacturing for approval . Please read FDA requirements before posting your opinions as facts 
      NWBO
      Golf4Food Golf4Food 4 minutes ago
      Happy new year mofos
      Boiler_Master Boiler_Master 4 minutes ago
      Market cap is 3.9M. Down side risk vs up side potential this year makes it a solid buy IMO. 
      EDXC
      Argeoz Argeoz 5 minutes ago
      I mean, if people are saying this what would they gain? Maybe prove to the board that’s not the case?
      CEOS
      Golf4Food Golf4Food 6 minutes ago
      Was a good day yesterday, profit is profit. I don’t think anyone knew it was going that high. Was in one earlier this year that went crazy in just one day then caput
      BullNBear52 BullNBear52 6 minutes ago
      LOL. for someone who doesn't follow biotechs its mildly amusing to weigh in on New Years Eve, As to the stock itself its extremely hard for biotech startups to find financial support while going through various trials of the next great breakthrough in healthcare.

      PFE seems to have giv
      PFE
      DewDiligence DewDiligence 6 minutes ago
      Re: Bachem

      I was looking for a Cliffs Notes synopsis, and you’ve given me a lot of new stuff to sift through! It will take me some time to digest this material and comment on it, if I can even understand it at all.

      Happy New Year and thank you for your valued contributi
      cjstocksup cjstocksup 6 minutes ago
      We know the FBI does not want you to know ISIS is here. We have terrorists all over this Country IMO.

      New Orleans attacker was flying a flag from the truck, but police at the scene intentionally covered it up.
      What was that flag?
      https://x.com/kikisknees/status/187444095
      Jetmek_03052 Jetmek_03052 7 minutes ago
      You want me to jump through hoops for you, because you don’t remember posts that are right here in the history of this board? That YOU can take the time to look up!?

      Do it yourself.
      DBMM
      shajandr shajandr 7 minutes ago
      Merry New Year, Janice. Stay healthy - there are some troublesome respiratory "bugs" and norovirus on the upswing recently. Plus the potential for a human variant of avian flu to spring forth. We already see in egg prices (and soon in dairy (milk/queso) prices also) the effects of avian influenza sp
      236T568 236T568 7 minutes ago
      Planned
      https://x.com/LasVegasLocally/status/1874594866786898411?s=19
      Golf4Food Golf4Food 7 minutes ago
      You on fire mang
      easymonee easymonee 7 minutes ago
      You continue to post that their will be 2 billion shares of dilution based on the min. price of .0005. You do realize the shares are going to be sold at different price ranges between .0005 min.-.01 max. (best-efforts basis at a fixed price of $[ ] per share) notice no fixed price, see below stateme
      MDCE SIPC
      al44 al44 8 minutes ago
      Under Obammy's watch-

      https://media.gettr.com/group6/getter/2025/01/01/12/1dc8bc06-86ce-01c8-9223-6d851ef7a916/199592f8d0f6354e1d78a07d4e4d4af5_768x0.png
      Golf4Food Golf4Food 8 minutes ago
      Possibly! May need a few dozen though lol
      cjstocksup cjstocksup 9 minutes ago
      🚨BREAKING: At least 10 people were killed and more than 30 injured in New Orleans after a man driving a pickup truck plowed into a large crowd in New Orleans.
      https://x.com/ImMeme0/status/1874451127816933447
      gawti88 gawti88 9 minutes ago
      yep, to take this to new levels, Mike will be great. Kate did a good job starting it up. Happy where we are going! 10c might be too cheap... man
      CEOS
      StayHumble StayHumble 10 minutes ago
      Lots of💹HISTORIC $HIRU XPERT interest wow💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/historical
      HIRU
      BBB BBB 10 minutes ago
      I own plenty - now F-OFF!!!!!
      SFIO
      xodcode xodcode 10 minutes ago
      What is most important IMO is that serious institutional investors see this and start to accumulate to where their holdings are over 80%. If that process starts tomorrow and continues all year then it will be a very good 2025 for Anavex shareholders.

      Yes, that is the longer term backd
      AVXL
      TucsonPhil TucsonPhil 10 minutes ago
      Bollocks.

      Oh, maybe with a 13000:1 RS
      KGKG
      cjstocksup cjstocksup 11 minutes ago
      JUST IN: New footage shows the moment Shamsud Din Jabbar allegedly navigated around a police cruiser barricade to carry out the terror attack.

      According to local reports, the city of New Orleans was replacing Bourbon Street bollards.

      “We have these hydraulic steel barri

      Your Recent History

      LSE
      IMM
      Immupharma
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads